×

Tag: MedUni Vienna

New biomarker can predict MS severity

It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this cannot be reliably done using...
New biomarker can predict MS severity

Vaccine supports immune response in immunosuppressed

Research from MedUni Vienna demonstrates that SARS-CoV-2 vaccination supports immune response in immunosuppressed patients Patients under immunosuppressive therapy can still develop good immune responses to...
Vaccine supports immune response in immunosuppressed

Lung cancer immunotherapy treatment

Potential marker for success of immunotherapy in the treatment of lung cancer: Lung cancer has the highest mortality rate of all cancers, and treatment options...
Lung cancer immunotherapy treatment

Chronic inflammatory liver disease

Chronic inflammatory liver disease: cell stress mechanisms identified as prognostic factor: PSC is a rare disease with a poor prognosis and can lead to cirrhosis...
Chronic inflammatory liver disease

Latest international brain tumour research

New findings about brain tumour development could lead to more effective treatment. For the first time in the world, an international study team with substantial...
Latest international brain tumour research